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mortality and a disturbing incidence of neurologic com-
plications.
The early clinical experience with HCA indicated that
there are 2 distinct pathophysiologic mechanisms of
cerebral damage after operations on the thoracic aorta.1
Most permanent serious neurologic complications are
the result of strokes, which are usually attributable to
embolic phenomena. In addition, many patients, espe-
cially those whose operations require longer intervals of
interruption of normal antegrade cerebral perfusion
(ACP), have more subtle but diffuse injury, resulting in
the clinical symptom complex that we have termed tem-
porary neurologic dysfunction (TND).1 This second
type of injury correlates with the duration of HCA and
D espite the improved results of more extensive oper-ations on the thoracic aorta since the introduction of
hypothermic circulatory arrest (HCA), these complex
procedures are still associated with a relatively high
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almost certainly results from inadequate cerebral pro-
tection.1 Despite the apparent reversibility of many
symptoms of TND, it has recently been shown that this
early manifestation of diffuse cerebral damage is asso-
ciated with long-term deficits in cognitive function.2-4
The relatively high rate of adverse neurologic out-
comes has prompted a search for alternative or supple-
mental methods of brain protection during prolonged
intervals of circulatory arrest required for complex aor-
tic operations. These methods include ACP and retro-
grade cerebral perfusion (RCP). We have used these
methods in conjunction with HCA. ACP was used
mainly to limit the duration of circulatory arrest, and
RCP was used mainly to flush out debris in an attempt
to prevent embolic strokes in patients at risk for partic-
ulate embolization. In addition, use of alternative can-
nulation sites other than the femoral artery was imple-
mented to eliminate the diseased descending aorta as a
source for retrograde embolization to the brain during
cardiopulmonary bypass.
The purpose of this report is to analyze neurologic
outcome (stroke and TND) at a single institution in all
patients who underwent repair of the thoracic portion
of the aorta through a median sternotomy with the use
of HCA. We also examined the effect of different neu-
roprotective perfusion techniques on the incidence of
brain injury in high-risk patients requiring complex
operations.
Patients and methods
Patient characteristics. A total of 717 consecutive
patients who survived thoracic aortic operations with HCA
through a median sternotomy at Mount Sinai Hospital from
August 1986 to November 1999 were reviewed. Median
age was 64 years (range, 8-89 years), and 58% of the
patients were older than 60 years at the time of the opera-
tion. Almost two thirds of the patients were male (66%).
The majority of patients, 458 (64%), were operated on elec-
tively, 100 (14%) were operated on urgently (between 16
and 72 hours after admission), and 159 (22%) were operat-
ed on on an emergency basis (within 16 hours after admis-
sion). One hundred seventy-five (24%) patients had under-
gone previous cardiac or aortic operations through a
sternotomy or lateral thoracotomy.
The underlying cause was dissection in 322 (45%) patients
and atherosclerosis in 125 (17%) patients. Of the remaining
270 patients, 154 (22%) were classified as having degenera-
tive aneurysms (featuring cystic medial necrosis), 54 (7.5%)
as having annuloaortic ectasia, and 31 (4.3%) as having the
features of Marfan syndrome. Sixty-two (8.6%) had miscel-
laneous lesions of mycotic or other cause.
A history of hypertension was the most common general
preoperative risk factor (56%), followed by a history of
smoking (47%) and diabetes mellitus (7.4%). Sixty-six
(9.2%) patients had a previous neurologic history (carotid
artery disease, transient ischemic attack, prolonged reversible
ischemic neurologic deficit, or frank stroke).
Surgical technique. Definition of the extent of replace-
ment was simplified for analysis into 2 major groups accord-
ing to the segment of the aorta that dominated the repair, as
described previously by Ergin and colleagues.1 A proximal
repair (replacement of the ascending aorta or the aortic root,
including portions of the proximal aortic arch, where the dis-
tal anastomosis was accomplished with a single suture line)
was done in 569 (79%) patients; a modified Bentall operation
was done in 66% of all proximal repairs. In 145 (20%)
patients the total arch was replaced, with reanastomosis of the
brachiocephalic vessels with an elephant trunk procedure in
25 (3.5%) patients.
For assessment of clot or atheroma, a computed tomo-
graphic or magnetic resonance imaging examination, as well
as transesophageal echocardiography, were performed before
the surgical procedure in all patients. In cases in which poten-
tially embolic material was found, alternative cannulation
sites other than the femoral artery (right axillary or left sub-
clavian artery) were considered. These alternative sites for
arterial cannulation were used routinely in the last 2 years.
Hemodynamic monitoring included radial arterial pressure
lines, as well as a pulmonary artery catheter. Since 1993, an
additional catheter was placed to sample jugular venous oxy-
gen saturation to estimate the cerebral metabolic rate before
induction of HCA. Transesophageal echocardiography was
routinely used to assess cardiac performance, intracardiac air,
flow conditions, and special aortic pathologic conditions.
All patients were operated on through a median sternotomy
incision and, unless contraindications were present, cannulat-
ed within the mediastinum by means of a low-resistance can-
nula in the aorta and a 2-staged venous cannula in the right
atrium. In patients in whom RCP was considered, a Y con-
nection was added to the arterial part of the circuit. After car-
diopulmonary bypass had been established, cooling was insti-
tuted to reach core temperatures of 10°C to 13°C.
In all cases of proximal repair, an open anastomosis was per-
formed. In total arch reconstructions, cerebral vessels were
excised on an island of native aorta, and an anastomosis of the
arch cap with a 16- to 20-mm Hemashield graft (Boston
Scientific Corporation, Natick, Mass) was performed, as
shown in Fig 1. All patients received 2 g of methylprednisolone
before institution of HCA and an additional 1.5 g of methyl-
prednisolone during the next 48 hours if HCA time exceeded
30 minutes. Rewarming was instituted gradually and discon-
tinued at a core temperature of 32°C to 33°C.
Neurologic evaluation. All patients who died intraopera-
tively or during the first 24 hours after the operation without an
opportunity for adequate evaluation of their neurologic status
were excluded from the study. This seemed appropriate
because even patients with a major neurologic insult during the
operation rarely die within such a short time. Patients were
considered to have had strokes if they exhibited the onset of
focal deficits postoperatively or were found to have a focal
lesion confirmed by means of computed tomographic scanning
or magnetic resonance imaging of the brain. Patients with neu-
rologic deficits that resolved before discharge were classified
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as having had transient strokes, distinguishing them from those
with permanent strokes, who had persisting deficits at the time
of discharge from the hospital. The total incidence of stroke
(transient plus permanent) was used for maximal power in uni-
variate and multivariate analysis.
For evaluation of TND (defined as postoperative confusion,
agitation, delirium, prolonged obtundation, or transient
parkinsonism), all patients who underwent their operation
before 1994 were excluded because of the institution of a
more scrupulous evaluation of this kind of neurologic injury
thereafter. Patients who died intraoperatively or whose post-
operative neurologic status could not adequately be assessed
before death, as well as those who underwent strokes, were
excluded from the analysis for TND.
Cerebral protection techniques. Selection of the perfu-
sion method used for cerebral protection was not random
but was related to the surgeon’s preference. There were 588
patients with only HCA, 43 in whom HCA was used in
conjunction with RCP, and 86 in whom selective ACP was
used (Table I). During an interval of several years in which
enthusiasm for RCP was relatively great, it was usually
chosen for patients in whom, as a result of the presence of
visible clot or atheroma in the aorta, the risk of emboliza-
tion was judged to be high. In contrast, ACP was dispro-
portionately frequently chosen for patients with more
extensive operations, in whom prolonged interruption of
the cerebral circulation was anticipated.
Comparative demographic variables show no significant
differences between the groups with different cerebral pro-
tection methods. However, emergencies were more frequent-
ly seen in the HCA only group (P = .001) because of the pre-
ponderance of acute type A dissections in this group,
commonly requiring a proximal repair. Dissection was the
most common cause among patients with HCA only (P =
.001), and aortic atherosclerosis was the most common cause
among patients with ACP. There were no patients with only
proximal repairs in the ACP group, whereas the operation
involved the proximal aorta in 69% of the HCA only group
(P = .001), who therefore had a much higher proportion of
aortic valve replacements or repairs (P = .001). As anticipat-
ed by the rationale for its use, clot or atheroma was more
prevalent in the RCP group (P = .002).
HCA was carried out as previously described in detail.
Core cooling with alpha-stat blood gas management was used
to achieve an esophageal temperature of 10°C to 13°C, and
the head was packed in ice during the interval of circulatory
arrest. In the later years of the study, especially when longer
intervals of HCA were anticipated, cooling was continued
until the jugular venous saturation exceeded 95%, indicating
maximal suppression of cerebral metabolism. Care was taken
to cool long enough to prevent a significant upward drift of
temperature during the interval of circulatory arrest.
Continuous RCP as a method of cerebral protection during
arrest of antegrade circulation or as a brief retrograde wash in
an attempt to flush out particular debris was used in only 43
patients. RCP flow was initiated through the superior vena
cava cannula and was regulated to achieve a pressure of 15 to
20 mm Hg in the superior vena cava.
In cases of ACP, the arterial line was inserted into a
Hemashield graft containing the island of arch vessels, and
perfusion was started after careful aspiration of the head ves-
sels (Fig 1). The temperature of the perfusate was maintained
between 10°C and 12°C, and the flow was adjusted to main-
tain an arterial pressure of 50 to 60 mm Hg. The graft con-
taining the island of arch vessels was then incorporated into
the aortic arch repair during a second short interval of HCA.
To compare the different techniques of cerebral protection,
we defined a period that reflects the time required to accom-
plish the technical maneuvers in the operation before resump-
tion of normal antegrade perfusion of the whole body and
refer to it as the total cerebral protection time (TCPT). In the
HCA group TCPT corresponds to the interval of circulatory
arrest, in the RCP group TCPT is equal to the sum of HCA
and RCP times, and in the ACP group TCPT is the sum of the
duration of HCA and of selective ACP. Table I shows the
TCPT for all 717 patients. Analysis of the specific effect of
perfusion techniques on neurologic outcome was restricted to
patients with TCPT from 40 to 80 minutes’ duration because
a 40-minute interval, both experimentally and clinically,
appears to be at the upper limit of protection afforded by
hypothermia alone. This TCPT interval in this series also
included adequate numbers of patients using each of the tech-
niques, allowing a more meaningful comparison.
Statistical methods. Comparisons of putative risk factors
between groups defined by use of different cerebral protec-
tion techniques, as well as univariate analyses of risk factors
for stroke or for TND, were conducted by using χ2 tests for
categoric variables; continuous variables were grouped and
examined for continuous trends or threshold values by means
of χ2 tests. Each set of univariate analyses of neurologic out-
come (for stroke or TND) was followed by stepwise logistic
regression to identify independent risk factors. In analyses
that included perfusion techniques, their independent influ-
ence was tested by adding to the model after other relevant
factors were identified.
The analyses for stroke and TND were conducted sepa-
rately. Risk factors for stroke were examined in all patients
who survived the operation long enough to allow neurolog-
ic evaluation, and risk factors for TND were assessed in
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Table I. TCPT for all 717 patients who survived
ascending aorta–aortic arch operations through a
median sternotomy incision
TCPT  HCA only RCP ACP
(min) (n = 588) (n = 43) (n = 86)
<20 152 3 0
20-30 237 9 1
30-40 116 13 1
40-60 71 14 26
60-80 12 4 29
80-100 0 0 12
>100 0 0 17
Total brain protection time is equal to HCA time for patients in whom this was
the only method of cerebral protection or HCA time plus the interval of RCP
or ACP.
patients after 1993 who survived the operation without
strokes, as explained earlier. These analyses could not
address the influence of cerebral protection technique on
neurologic outcome because the choice of cerebral protec-
tion technique was confounded with TCPT, as seen in Table
I. All 3 cerebral protection techniques were adequately rep-
resented only for TCPTs between 40 and 80 minutes.
Therefore, the analysis of risk factors for stroke and for
TND was repeated as outlined above in the subgroup of
patients with a TCPT of 40 to 80 minutes, including testing
for the independent influence of cerebral protection tech-
nique on neurologic outcome.
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Fig 1. The simplified technique for selective ACP used at Mount Sinai, showing incorporation of the cerebral ves-
sel graft into the arch repair. A, The cap of cerebral vessels, dissected from the native arch, is sutured to an appro-
priately shaped 14- to 16-mm Hemashield graft by using a running 3-0 polypropylene suture reinforced with Teflon
felt. B, An arterial inflow cannula has been inserted, the proximal end of the graft has been clamped, and selective
ACP has been initiated with blood at 15°C to 20°C to achieve pressure of 50 to 60 mm Hg in either radial artery
(flow rate, 800-1200 mL/min). A second Hemashield graft is shown after the reinforced distal anastomosis has been
completed and the proximal anastomosis is being constructed. C, The arch reconstruction is being completed by
means of a graft-to-graft anastomosis of the proximal-distal arch and cerebral vessel grafts during a brief (5-10
minute) interval of HCA. D, The completed repair. This technique can be combined with axillary artery cannula-
tion to minimize risk of embolization.
To provide greater statistical power in identifying risk fac-
tors, we examined transient and permanent strokes together.
The question of whether this approach is justified (ie,
whether factors associated with the risk of permanent stroke
are the same as those associated with transient stroke) was
addressed in 2 ways. Among the patients who had a stroke, χ2
tests were used to compare the proportions of patients with
permanent and transient strokes separately for each putative
risk factor. In addition, the data were entered in an ordinal
stepwise logistic model with the outcomes of no stroke, tran-
sient stroke, and permanent stroke and tested for the homo-
geneity of 2 sets of odds ratios (ORs): (1) permanent or tran-
sient stroke versus no stroke and (2) permanent stroke versus
transient or no stroke.
All data were analyzed with SAS software (SAS Institute,
Inc, Cary, NC) on a VAX computer (Compaq Computer
Corporation, Houston, Tex).
Results
Of all patients who underwent ascending aorta–aortic
arch operations through a median sternotomy during the
interval under study, 17 of the 734 patients died in the
operating room or shortly thereafter before adequate
assessment of neurologic function was possible. Fifty-
six of the operative survivors died before discharge from
the hospital, resulting in an overall mortality of 10%.
The adverse effect of neurologic injury on recovery after
aortic operations is readily apparent from mortality sta-
tistics: 41% of patients with permanent strokes died
before hospital discharge. Use of RCP was also associ-
ated with a slightly but not significantly higher mortali-
ty than other methods of cerebral protection.
Of the patients who survived, as shown in Fig 2,
patients with no neurologic complications had a medi-
an length of stay significantly shorter than those with
TND. Patients with either transient or permanent stroke
had considerable further increases in median length of
hospital stay than did patients without neurologic
injury.
Stroke. Among all 717 patients in the study, a tran-
sient stroke occurred in 24 (3.3%) patients, and 37
(5.7%) patients had a permanent stroke. There were no
historical differences in the prevalence of stroke over
the interval under scrutiny from 1986 to 1999 (P = .7).
Univariate analysis for stroke (either transient or per-
manent) revealed a number of preoperative and intra-
operative risk factors (Table II). Preoperative predictors
of stroke included age greater than 60 years (P = .001),
emergency operation (P = .006), atherosclerosis as the
underlying cause (P = .001), presence of coronary
artery disease (P = .02), and occurrence of new preop-
erative neurologic symptoms (P = .01). A history of
smoking (P = .05) or of previous neurologic symptoms
(P = 0.11) was marginally significant as a risk factor
for stroke. Intraoperative variables significant as risk
factors for stroke included total arch repair (P = .006),
contained hematoma (P = .002), presence of visible
clot or atheroma (P = .001), and TCPT (P = .001).
Among all the factors tested, only total arch repair, the
presence of contained hematoma (a sign of imminent
rupture), and TCPT showed a significant differential
effect on transient versus permanent strokes, all predis-
posing toward more permanent strokes. The incidence
of transient and permanent strokes in relation to each
factor is also shown in Table II.
No comparison of cerebral protection techniques in
relation to stroke incidence was undertaken in the
group as a whole because of the inextricable intertwin-
ing of different cerebral protection techniques and
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Fig 2. Effect of neurologic injury on median length of hospitalization in all patients who survived until discharge
from the hospital. LOS, Length of stay; TND, temporary neurologic dysfunction. *P < .001 versus no deficit.
TCPT. Patients undergoing ACP and RCP had signifi-
cantly longer TCPTs than patients undergoing HCA. In
addition, almost all patients undergoing ACP had total
arch replacement, which carries a high risk of stroke,
whereas the proportion of arch replacements when
either RCP or only HCA were used was smaller. The
groups with different cerebral protection techniques
also varied in preoperative risk factors for stroke. The
distribution of emergency and elective operations dif-
fered; there were more patients with visible clot or
atheroma in the group with RCP, and more patients
with atherosclerotic aneurysms were in the ACP group.
In the multivariate analysis of the group as a whole,
independent risk factors for stroke were as follows: age
greater than 60 years (P = .0006; OR, 4.4; Fig 3); emer-
gency operation (P = .023; OR, 2.2); the presence of
clot or atheroma (P < .001; OR, 4.2); and TCPT (P =
.001; OR, 1.02/min; Fig 4). A steady increase in the
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Table II. Univariate and multivariate analysis for stroke in all 717 patients
Any stroke
Transient Permanent
n stroke (%) stroke (%) Univariate Multivariate OR
Preoperative factors
Age P = .001 P = .006 4.4
Age ≤60 y 302 1.3 1.0
Age >60 y 415 4.8 8.2
Ever smoked P = .05
No 380 2.4 4.2
Yes 337 4.5 6.2
Coronary artery disease P = .02
No 575 2.8 4.5
Yes 142 5.6 7.8
Urgency P = .006 P = .02 2.2
No emergency 159 3.1 3.9
Emergency 558 4.4 9.4
Cause P = .001
Atherosclerosis 125 6.4 11.2
Dissection 322 3.7 6.2
Others 270 1.5 1.1
Previous neurologic history P = .12
No 651 3.2 4.8
Yes 66 4.6 9.1
New preoperative neurologic
symptoms P = .012 P = .05 2.9
No 689 3.2 4.8
Yes 28 7.1 14.3
Marfan syndrome P = .08
No 686 3.5 5.4
Yes 31 0 0
Intraoperative factors
Extent of operation P = .006
Proximal 572 3.5 3.5
Arch 145 2.8 11.7
Mitral valve replacement or other P = .48 P = .055 3.7
concomitant procedure
No 691 3.2 5.2
Yes 26 7.7 3.9
Contained hematoma P = .002
No 622 3.4 3.9
Yes 95 3.2 13.7
Clot or atheroma P = .001 P < .001 4.4
No 601 2.5 2.7
Yes 116 7.8 18.1
TCPT P = .001 P = .001 1.02/min
risk of stroke with increasing TCPT was evident in the
HCA group and the ACP group but not in the RCP
group, most of whose TCPTs were between 20 and 60
minutes. The presence of new preoperative neurologic
symptoms, frequently found in patients with acute dis-
sections, was of borderline significance (P = .06; OR,
2.8). All factors except TCPT were homogeneous for
transient and permanent stroke: longer TCPT was asso-
ciated with greater risk of permanent stroke.
When only the 156 patients with prolonged TCPT
(40-80 minutes) were included in a multivariate analy-
sis, age greater than 60 years was the only significant
risk factor for stroke (P = .037; OR, 8.9). There was no
influence of perfusion technique on the incidence of
stroke in this group with prolonged TCPT. Some cau-
tion should be exercised in interpreting the failure of
cerebral protection techniques to influence the rate of
stroke. The apparent inability of these techniques to
prevent strokes might be influenced by the fact that the
patients with RCP and ACP were at a higher risk for
strokes because of other predisposing factors, such as a
higher incidence of coronary artery disease, of athero-
sclerotic origin of the aneurysm, and of more extensive
operation (Table III). Patients with RCP also had a
higher incidence of clot or atheroma and higher rates of
concomitant coronary artery bypass operations. On the
other hand, patients with HCA were more likely to
have undergone operations on an emergency basis and
to have had dissections and new neurologic symptoms,
factors associated with increased risk of stroke.
TND. For all patients operated on after 1993 (n =
453), the TND rate was 30%. As was true for stroke,
there was no influence of year of operation on the risk
of TND (P = .993) during this period.
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Table III. Characteristics of patients with TCPT between 40 and 80 minutes
All patients HCA HCA + RCP HCA + ACP
(n = 156) (n = 83) (n = 18) (n = 55) P value
Preoperative factors
Age .126
Age ≤60 y 45 (28.8%) 21 (25.3%) 3 (16.7%) 21 (38.2%)
Age >60 y 111 (71.2%) 62 (74.7%) 15 (83.3%) 34 (61.8%)
History of hypertension .091
No 47 (30.1%) 31 (37.3%) 5 (27.8%) 11 (20.0%)
Yes 109 (69.9%) 52 (62.7%) 13 (72.2%) 44 (80.0%)
Coronary artery disease .079
No 123 (78.8%) 71 (85.5%) 12 (66.7%) 40 (72.7%)
Yes 33 (21.1%) 12 (14.5%) 6 (33.3%) 15 (27.3%)
Urgency .005
Emergency 41 (26.3%) 32 (38.5%) 2 (11.1%) 7 (12.7%)
No emergency 115 (63.7%) 51 (61.5%) 16 (88.9%) 48 (87.3%)
Cause .001
Atherosclerosis 48 (30.8%) 17 (20.5%) 6 (33.3%) 25 (45.5%)
Dissection 94 (60.3%) 59 (71.1%) 7 (38.9%) 28 (50.9%)
Others 14 (8.9%) 7 (7.4%) 5 (27.8%) 2 (3.6%)
New preoperative neurologic symptoms .064
No 150 (96.2%) 77 (92.8%) 18 (100%) 55 (100%)
Yes 6 (3.8%) 6 (7.2%) 0 (0%) 0 (0%)
Intraoperative factors
Extent of operation .001
Proximal 66 (42.3%) 57 (68.7%) 9 (50.0%) 0 (0%)
Arch 90 (57.7%) 26 (31.3%) 9 (50.0%) 55 (100%)
CABG .060
No 131 (84.0%) 67 (80.7%) 13 (72.2%) 51 (92.7%)
Yes 25 (16.0%) 16 (19.3%) 5 (27.8%) 4 (7.3%)
Contained hematoma .037
No 128 (82.1%) 63 (75.9%) 14 (77.8%) 51 (92.7%)
Yes 28 (17.9%) 20 (24.1%) 4 (22.2%) 4 (7.3%)
Clot or atheroma .002
No 101 (64.7%) 57 (68.7%) 5 (27.8%) 39 (70.9%)
Yes 55 (35.3%) 26 (31.3%) 13 (72.2%) 16 (29.1%)
CABG, Coronary artery bypass grafting.
Univariate analysis demonstrated a number of preop-
erative variables as significant risk factors for TND
(Table IV): female sex (P = .007); age (P = .001, Fig 5);
the presence of coronary artery disease (P = .038); dis-
section as the underlying cause of aortic disease 
(P = .001); emergency operation (P = .004); and a histo-
ry of previous neurologic events (P = .021).
Intraoperative factors that reached significance for TND
in univariate analysis (Table IV) included the following:
total arch operation (P = .001); concomitant coronary
artery bypass grafting procedure (P = .001); blood in the
pericardium (P = .027); contained hematoma (P = .015);
appearance of clot or atheroma (P = .001); and TCPT 
(P = .001, Fig 6).
Multivariate analysis revealed the following indepen-
dent risk factors for TND: age as a continuous variable
(P = .0001; OR, 1.06/y); dissection (P = .001; OR, 2.2);
need for coronary artery bypass grafting (P = .006; OR,
2.1) or other procedures (P = .023; OR, 3.4); and TCPT
(P = .001; OR, 1.02/min; Figs 4 and 5).
In the group with TCPTs from 40 to 80 minutes’
duration (n = 91), age (P = .002; OR, 1.06/y), athero-
sclerosis (P = .009; OR, 14.9), and dissection (P =
.028; OR, 8.1) were all significant independent risk
factors for TND (Table V). The use of ACP significant-
ly decreased the risk for TND in this group (P = .048;
OR, 0.33). To isolate the apparent influence of ACP in
reducing the incidence of TND from the effects of
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Fig 3. Effect of increasing age on incidence of stroke, transient or permanent, in all patients (n = 717).
Fig 4. Effect of increasing duration of cerebral protection (TCPT) on incidence of stroke, either transient or per-
manent, in all patients (n = 717). In the HCA group TCPT corresponds to the interval of HCA, in the RCP group
TCPT is equal to the sum of HCA and RCP times, and in the ACP group TCPT is the sum of the duration of HCA
and selective ACP.
other covariables, we conducted a stringent stepwise
analysis for these confounding factors. The addition of
the factors to the model did not change the observed
influence of ACP in reducing the incidence of TND. (P
values for these factors ranged from .29 to .99 in the
model, with ACP maintaining its predictive value.)
Although patients undergoing RCP appeared to have
had a slightly higher incidence of TND than those with
HCA alone, the difference did not reach statistical sig-
nificance.
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Table IV. Univariate and multivariate analysis for TND for all patients after 1993 (n = 453)
TND
n % Univariate Multivariate OR
Preoperative factors
Sex P = .007
Female 152 38.2
Male 301 25.9
Age P = .001
Age ≤60 y 192 16.7 P < .001 1.06/y
Age > 60 y 261 39.9
History of hypertension P = .110
No 182 25.8
Yes 271 32.8
Coronary artery disease P = .038
No 339 27.4
Yes 114 37.7
Urgency P = .004 P = .004 2.0
Emergency 92 42.4
No emergency 361 26.9
Cause P = .001
Atherosclerosis 69 42.0
Dissection 179 40.8 P = .001 2.2 vs all
Others 205 16.6
Previous neurologic history P = .021
No 414 28.5
Yes 39 46.2
Marfan syndrome P = .058
No 434 30.9
Yes 19 10.5
Aortic valve disease P = .007
None 324 34.3
Prosthetic 57 21.1
Bicuspid 72 18.1
Intraoperative factors
Extent of operation P = .001
Proximal 369 26.6
Arch 84 45.2
CABG P = .001 P = .007 2.0
No 352 25.6
Yes 101 45.5
Mitral valve replacement or other concomitant procedures P = .092 P = .02 3.3
No 434 29.3
Yes 19 47.4
Blood in pericardium P = .027
No 424 28.8
Yes 29 48.3
Contained hematoma P = .015
No 407 28.3
Yes 46 45.7
Clot or atheroma P = .001 P = .09 1.8
No 408 27.0
Yes 45 57.8
Cardiopulmonary bypass time P = .039
TCPT P = .001 P < .001 1.02/min
CABG, Coronary artery bypass grafting.
Although there was no effect of TCPT on the inci-
dence of TND in the 40- to 80-minute subgroup, the
data from the larger group (Fig 7) did show a signifi-
cant effect of TCPT on TND. Because TCPT exceeding
80 minutes involves predominantly the use of ACP, this
indicates that even ACP is not quite safe for prolonged
periods. 
Discussion
The best approach to protecting the brain during
operations on the thoracic portion of the aorta, in which
the arterial blood supply has to be interrupted tem-
porarily, is still a matter of controversy.5 Our approach
has been to try to maximize protection during HCA by
cooling thoroughly and by limiting the duration of
HCA. During the interval under study, we used RCP
mainly with the aim of reducing embolization but
relied principally on ACP as an adjunct to HCA when
longer durations of HCA were anticipated.
Although experience with RCP has now lasted
almost 10 years,6 there is still controversy about
whether RCP has a neuroprotective effect above and
beyond that provided by HCA. Although some uptake
of oxygen during retrograde flow clearly occurs, most
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Fig 5. Effect of increasing age on incidence of TND, as defined in the text, in all patients after 1993 who survived
operation without stroke (n = 453).
Fig 6. Effect of increasing duration of cerebral protection (TCPT) on incidence of TND, as defined in the text, in
all patients after 1993 who survived operation without stroke (n = 453). In the HCA group TCPT corresponds to
the interval of HCA, in the RCP group TCPT is equal to the sum of HCA and RCP times, and in the ACP group
TCPT is the sum of the duration of HCA and of selective ACP.
of the efforts to document significant improvement in
cerebral metabolic function as a result of nutritive flow
during RCP have failed. Furthermore, experimental
studies have shown that significant shunting of blood
away from the brain occurs during RCP through ve-
novenous anastomoses.7 Nevertheless, there may be a
positive influence of RCP on cooling, which helps to
protect the brain, especially in those patients in whom
systemic cooling is not as thorough and prolonged as it
should be. We continue to believe that a major benefit
of RCP in the studies of others—usually with a histor-
ical control group and with duration of RCP so short
that good results would be anticipated with use of HCA
alone—can be explained largely by the improved cool-
ing brought about by continuous bathing of the brain
with cold blood during RCP. This effective cooling pro-
vided by RCP may make a difference, especially if the
initial cooling interval is short and the head is not
packed in ice. Several experimental studies reinforce
this view.8
Others have shown a remarkable positive effect of
RCP: a dramatic reduction of the stroke rate and a ben-
eficial effect on both stroke rate and mortality.9-11 In the
current and in earlier12 studies, however, we have been
unable to demonstrate any benefit of RCP in our
patients. Experimental data from our laboratory sug-
gest that RCP, especially at high pressures, although
successful in removing some emboli, may aggravate
cerebral injury.13 Although the greater prevalence of
patients with clot or atheromata in the RCP group in
the current study may partially explain why our results
show no decrease in the prevalence of stroke with RCP,
it nevertheless is also possible that flushing the arterial
vessels by using RCP may not be effective in prevent-
ing stroke. Hospital mortality was higher among
patients in whom RCP was used, and the TND rate in
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Table V.  Univariate and multivariate analysis for TND (TCPT, 40-80 minutes), excluding all patients with stroke
(n = 91)
TND
n % Univariate Multivariate OR
Preoperative factors
Sex P = .06
Female 38 57.9
Male 53 37.7
Age P = .001 P = .002 1.06/y
Age ≤60 y 31 19.4
Age >60 y 60 60.0
Cause P = .05
Atheromatosis 25 64.0 P = .009 14.9 vs all others
Dissection 56 42.9 P = .03 8.1 vs all others
Others 10 20.0
Reoperation P = .040
No 64 53.1
Yes 27 29.6
Marfan syndrome P = .103
No 88 47.7
Yes 3 0
Intraoperative factors
CABG P = .02
No 76 40.8
Yes 15 73.3
Clot or atheroma P = .03
No 72 40.3
Yes 19 68.4
Blood in pericardium P = .09
No 83 43.4
Yes 8 75.0
Perfusion type
HCA only 34 52.9
RCP 13 69.2 P = .34 2.2 vs HCA only
ACP 44 34.1 P = .05 0.3 vs HCA only
the group with TCPTs between 40 and 80 minutes was
significantly higher with RCP than with ACP.
Furthermore, RCP resulted in no reduction of TND
compared with HCA alone, reinforcing the notion that
RCP probably has no nutritive value for brain tissue.
The induction of cerebral edema, documented in our
animal studies of RCP,13 cannot easily be demonstrated
in the clinical situation but may be another reason for
our repeated observation of delayed neurologic recov-
ery postoperatively in patients treated with RCP.
In contrast to the lack of benefit seen with adjunctive
RCP, ACP is associated with better cerebral recovery
after prolonged HCA in our study. ACP often requires
complicated cannulation techniques, and accidental
embolization of atheromatous debris during manipula-
tion of the arch vessels is a widely known and justly
feared complication. Several modifications of selective
antegrade perfusion have been introduced, including
variations in cannulation sites and use of lower perfu-
sion temperatures,14-16 which have resulted in recent
favorable outcomes in the hands of several investiga-
tors.17 With the use of an island of arch vessels, as
shown in Fig 1, ACP can be initiated through the graft
during an initial interval of HCA and maintained until
the aortic repair is completed (by means of anastomo-
sis of the principal aortic graft with the island contain-
ing the arch vessels during a second interval of HCA).
This method has gradually become the technique of
choice in our institution for aortic arch operations when
more extensive operations are planned and may have
contributed to the observed reduction of neurologic
morbidity when ACP was used.
Our data show that the TND rate in the patients with
prolonged TCPTs between 1994 and 1996 was 53%
compared with 39% after 1996, which was when we
began to use ACP more frequently in patients with
more extensive operations. The significantly lower rate
of TND after 40 to 80 minutes of TCPT with ACP
when compared with RCP or HCA alone in this study
is convincing evidence of the superior cerebral protec-
tion provided by ACP when prolonged operations are
undertaken. Antegrade administration of oxygenated
cold blood delivers energy for brain tissue, can remove
toxic metabolites, and improves cooling of the brain,
thereby prolonging the safe duration of HCA.
However, our results do not imply that ACP gives us
the luxury of unlimited time to complete an aortic
repair. Our data suggest that there may be a critical
point, perhaps a TCPT exceeding 80 minutes, beyond
which cerebral protection, even with ACP, is subopti-
mal. Such a time limit has to be taken into considera-
tion, especially when contemplating use of multives-
sel aortic arch grafts, which require a separate
anastomosis for each cerebral vessel. Although these
techniques may result in a more complete resection of
the diseased aorta and avoid reconstruction in the
atheromatous arch near the origin of the cerebral ves-
sels, the decrease in the risk of embolization inherent
in this method may come at the price of exceeding the
duration of safe ACP.
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Fig 7. Effect of increasing duration of cerebral protection on incidence of TND, as defined in the text, fractionat-
ed according to the cerebral protection method in all patients who survived operation without stroke since 1993 
(n = 453). In the HCA group TCPT corresponds to the interval of HCA, in the RCP group TCPT is equal to the
sum of HCA and RCP times, and in the ACP group it is the sum of the duration of HCA and of selective ACP.
Although differences in patient selection require that comparisons between the groups undergoing different modes
of cerebral protection be undertaken with caution, it is interesting to note that the incidence of TND with increas-
ing TCPT appears to increase more sharply with RCP than with HCA alone, and that the levels of TND with ACP
are comparatively low despite longer TCPT.
In contrast to its positive effect on TND, ACP has not
been helpful in preventing stokes. The results of the
multivariate analysis in all 717 patients for stroke
showed that almost all the important factors predispos-
ing to stroke are patient or disease related. Age greater
than 60 years and intraoperatively observed clots or
atheromata were the strongest predictors for stroke.
Emergency operation and occurrence of new preopera-
tive neurologic symptoms, which also increase the risk
of stroke, cannot be influenced by surgical techniques,
but these data argue that aggressive elective treatment
of aortic aneurysms should reduce the incidence of
adverse outcome after aortic operations. These results
are not unexpected,2 but the consistent reports of better
outcomes after elective rather than emergency aortic
operations merit reiteration.
Compared with our earlier experience reported in
1994, only TCPT emerged as an additional risk fac-
tor for stroke.1 The idea that very long cerebral pro-
tection times may contribute to the incidence of
stroke seems now, with an increasing number of
patients, to be a consistent finding in our patient pop-
ulation.18 We still believe that stroke is predominant-
ly embolic in origin, but the occurrence of mild dif-
fuse cerebral injury (reflected clinically by higher
rates of TND) with prolonged TCPTs may aggravate
the effect of an embolic stroke in some cases, allow-
ing prolonged TCPT to emerge as a risk factor if
enough patients are studied. An embolus that blocks
flow to a small defined area may lead to a clinically
detectable stroke only if an additional prolonged
period without adequate perfusion to surrounding tis-
sues occurs. An effect of prolonged cerebral ischemic
time on the incidence of stroke has previously been
documented by Svensson and colleagues,19 who
showed that HCA intervals longer than 40 minutes
were associated with higher stroke rates. However, in
our current subgroup of patients with TCPTs from 40
to 80 minutes, there was no indication that longer
times within this range are associated with higher
stroke rates, which is consistent with our earlier stud-
ies in smaller numbers of patients. We think that the
higher stroke rates with extremely long TCPTs in the
current group as a whole are largely a consequence of
the association of long TCPTs with more extensive
operations involving the aortic arch in patients with
underlying atheromatous lesions predisposing to
stroke.
The subgroup with TCPTs from 40 to 80 minutes
affords us a unique opportunity to compare perfusion
techniques with regard to effectiveness of cerebral pro-
tection, as reflected by the incidence of TND. In the
subgroup analysis, as in the entire cohort, older age
remains an important risk factor for TND. Another
powerful predictor for TND is a cause involving either
atherosclerosis or dissection. In addition, a remarkable
protective effect of ACP is seen in this group of patients
with prolonged operations, reinforcing the idea that
providing an effective blood supply to the brain intra-
operatively has a positive influence on cerebral recov-
ery, even when the brain is protected by deep cooling.
Conclusions
Even though current brain protection techniques
are not able to prevent embolic damage, this study
demonstrates that ACP can reduce the more subtle
global cerebral injury seen with inadequate cerebral
protection during aortic operations reflected by a
reduced incidence of TND when prolonged HCA is
compared with ACP. Stroke rate is primarily a
patient- and disease-related problem and seems inde-
pendent of the use of different cerebral protection
techniques, although its incidence is increased with
very long TCPTs. The incidence of stroke is more
likely to be effectively reduced by avoiding dislodg-
ment of emboli, perhaps by modifying cannulation
sites (eg, by using axillary cannulation). Unpublished
data from our own experience seem to support this
thesis. The positive effect of ACP on TND rate favors
this technique when more extensive operations are
planned. ACP allows aggressive treatment of more
complex aortic pathologic conditions, although the
safety of even ACP seems to be compromised when it
exceeds 80 minutes.
A prospective randomized study with rigorous mea-
surement of neurologic outcome would likely settle
any lingering controversy about the best method for
cerebral protection during aortic operations, but it is
hard to imagine launching such a trial under current
circumstances, when the results of admittedly imper-
fect clinical and experimental studies create a strong
subjective bias favoring one approach over another
under specific clinical circumstances. It seems clear
that in operations likely to require more than a 40-
minute interruption of normal circulation to the brain,
ACP is the cerebral protection method of choice.
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Discussion
Dr R. Scott Mitchell (Woodside, Calif). Drs Hagl and
Ergin and the Mount Sinai group are to be congratulated for
yet another contribution toward our understanding of mecha-
nisms of neurologic injury during HCA. Their clinical and
laboratory research could almost be viewed as the Mount
Sinai quest for the holy grail.
In brief, these advances include the following:
1. Use of alternative cannulation sites to minimize retro-
grade propagation of aortic and iliac artery atheroem-
boli
2. Prolonged core cooling to core temperatures of 10°C
to 13°C to assure homogeneous cerebral hypothermia 
3. Increasing dependence on antegrade cerebral perfu-
sion for neurologic protection during prolonged pro-
cedures
Operative mortality was 10% and was profoundly affected
by neurologic injury, which increased hospital mortality by
400%. Interestingly, for stroke, only increasing age correlat-
ed with increased risk. However, for the somewhat more sub-
tle TND, which occurred in 30% of patients, increasing age,
cause of atherosclerosis or dissection, and RCP adversely
affected results. Although this is not a randomized trial, and
indeed the operative management changed substantially over
the time period of this study, I do believe these results consti-
tute the best available technique.
I do have 3 questions. First, with the substantial amount of
data coming from Japan, how do you reconcile your findings
with many of the reports, like that from Osaka, that have
demonstrated no adverse effect and in fact have demonstrat-
ed a good effect of RCP for prolonged circulatory arrest
times?
Dr Hagl. Thank you very much, Dr Mitchell, for your kind
remarks. We think that the positive effects which were shown
from groups using RCP are due to better cooling. The Mount
Sinai group cools more aggressively (ie, to 10°C or 12°C)
than most other groups. Surgeons who cool to just 18°C and
then perfuse the brain in a retrograde manner may have more
complete cooling with RCP than otherwise. It may also be
theoretically possible to flush out some emboli by using the
RCP technique. Nevertheless, we have not seen any benefi-
cial effects in our patients with that method.
Dr Mitchell. Second, did you attempt to analyze any sort
of a subcategory for those patients in whom you did these
more proximal alternative cannulations on axillary, subcla-
vian, innominate arteries?
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Dr Hagl. This was not part of the present study. We have,
however, analyzed our results for axillary cannulation in a
single surgeon’s experience, and it seems, comparing the
femoral artery cannulation with the axillary cannulation, that
axillary cannulation has a much better outcome and a much
lower stroke rate. Therefore, we have begun using axillary
cannulation almost exclusively in the last 2 years and try to
avoid femoral cannulation if possible.
Dr Mitchell. Because there still appears to be some substan-
tial neurologic injury with prolonged periods of HCA, do you
think we should perhaps return to selective antegrade continu-
ous perfusion for these difficult and prolonged arch cases?
Dr Hagl. I think what we showed here is that it is definite-
ly useful to do ACP in more extensive operations with pro-
longed periods of HCA. To offer the brain some cold oxy-
genated blood seems to protect the cerebrum from the more
subtle neurologic injury, what we term TND. We still think
that TND is probably caused by imperfect brain protection. I
would like to emphasize that I think it is very important to do
ACP with cold, rather than warm, blood.
Dr Dev Manhas (Seattle, Wash). I enjoyed the article very
much. I have a question about ACP. Are you perfusing both
the innominate and the left common carotid arteries? What is
your perfusion rate and pressure monitoring when you do
that? Are you checking the carotid arteries preoperatively by
using Doppler ultrasonography? 
Dr Hagl. What we do is to create an island of native arch
and perfuse the head vessels through an attached graft with-
out cannulation of the native vessel. The perfusion rate is
approximately 700 to 1200 mL/min, but we believe it is more
important to measure the pressure in the radial artery. We rely
more on pressure measurement than on the flow rate.
Concerning your second question, we do not routinely
carry out preoperative evaluation of carotid arteries unless
specific indications like a bruit or a neurologic history are
present.
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